Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway

While cisplatin is a first-line chemotherapeutic drug commonly used to treat patients with oral squamous cell carcinoma (OSCC), the cisplatin-resistance poses a major challenge for its clinical application. Recent studies have shown that quercetin, a natural flavonoid found in various plants and foo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Guo, Shu, Xiong, Xi-Kun, Peng, Bao-Ying, Huang, Jun-Ming, Chen, Mei-Fen, Wang, Feng-Yan, Wang, Jian-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746132/
https://www.ncbi.nlm.nih.gov/pubmed/31528215
http://dx.doi.org/10.7150/jca.31045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746132/
https://www.ncbi.nlm.nih.gov/pubmed/31528215
http://dx.doi.org/10.7150/jca.31045

Ejemplares similares